BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

DRMA

No price yet

Announcements

Nothing here yet

Daily updates

  • Dermata Reports Initial Skin-Enhancement Results for Tome Foundational TreatmentOct 15, 2026

FDA designations

Nothing here yet

News

  • Dermata Therapeutics launched its Tome Foundational Treatment commerciallyAug 25, 2026
  • Dermata opened preorders for Tome Foundational Treatment ahead of its commercial launchAug 21, 2026
  • Dermata Therapeutics announced the commercial launch date for Tome foundational treatmentAug 6, 2026
  • Dermata received acceptance of an Australian patent for its dermal filler delivery systemApr 2, 2026
  • Dermata Therapeutics announces up to $12.4 million private placement priced at-the-marketDec 24, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy